Michael Davis
Lawyers
Filters
Lightyear Capital partners with Schellman & Company
We advised Lightyear on the transaction and the related financing arrangements
Highland Transcend Partners I merger with Pharmapacks
We are advising Highland Transcend Partners I, a SPAC, on the transaction
Lightyear sale of Datalot to Centerfield
We advised Lightyear on the sale
Charles River Laboratories acquisition of Vigene Biosciences
We are advising Charles River on the acquisition
Lightyear Capital to sell Therapy Brands to KKR
We advised Lightyear Capital on the sale
Charles River Laboratories $875 million acquisition of Cognate
We advised Charles River on the acquisition of a cell and gene therapy contract development and manufacturing organization
RTL Group $1.17 billion sale of SpotX to Magnite
We are advising RTL Group on the sale of its U.S. ad-tech company
Bertelsmann $2.175 billion acquisition of Simon & Schuster
Davis Polk is advising Bertelsmann on the $2.175 billion acquisition by its global trade book publishing group, Penguin Random House, of Simon & Schuster from ViacomCBS. The transaction…
Traton $3.7 billion acquisition of Navistar International
Davis Polk is advising Traton SE on its $3.7 billion acquisition of Navistar International Corp. Traton, which already owns an approximately 16.7% stake in Navistar, will acquire all…
Lightyear Capital & Ontario Teachers’ Pension acquisition of Allworth Financial
Davis Polk is advising Lightyear Capital and Ontario Teachers’ Pension Plan Board on their acquisition of wealth management firm Allworth Financial from private equity funds managed by…